Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    " January 11, 2012":" February 10, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 11, 2012":" February 10, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Use of Incentives to Engage Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
2 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
3 Completed A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
Condition: HIV Infections
Interventions: Biological: Tat;   Biological: Placebo
4 Completed
Has Results
Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: Stribild
5 Completed
Has Results
Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice
Condition: HIV Infections
Intervention:
6 Completed
Has Results
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Condition: HIV Lipodystrophy
Interventions: Drug: Human recombinant leptin ("metreleptin");   Drug: Placebo
7 Active, not recruiting Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa
Condition: HIV Prevention
Interventions: Other: Testing and Counseling;   Behavioral: Brief Motivational Interview (BMI);   Behavioral: Integrated Family and Cognitive Behavioral Therapy
8 Completed
Has Results
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
Condition: HIV
Interventions: Drug: Lisinopril;   Drug: Placebo
9 Active, not recruiting Vitamin D Supplementation in HIV Youth
Condition: HIV+
Intervention: Drug: Vitamin D3
10 Active, not recruiting Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Conditions: HCV Coinfection;   HIV Infection
Intervention: Drug: Nitazoxanide
11 Completed
Has Results
Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Condition: Human Immunodeficiency Virus
Intervention:
12 Terminated Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Condition: HIV
Interventions: Drug: 3 drug regimen: Tenofovir DF and Emtricitabine; Ritonavir-boosted Atazanavir;   Drug: Ritonavir, Atazanavir, Truvada
13 Completed
Has Results
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
Condition: HIV-1 Infection
Intervention: Drug: Atazanavir/ritonavir monotherapy
14 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
15 Completed The Neurocognitive Sub-study of Encore1
Condition: HIV
Intervention: Drug: Efavirenz
16 Completed
Has Results
Bone and Body Comp: A Sub Study of the SECOND-LINE Study
Condition: HIV
Interventions: Drug: Lopinavir / ritonavir + 2-3N(t)RTI;   Drug: Lopinavir /ritonavir + raltegravir
17 Completed Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test
Conditions: HIV;   Syphilis
Intervention: Device: MBIO POC combined HIV syphilis test ( SnapEsi)
18 Completed Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1 Infection
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan
19 Active, not recruiting Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
Conditions: HIV;   Adolescent Behavior;   Gender
Interventions: Other: Male-Specific Intervention Package;   Other: Female-Specific Intervention Package;   Drug: Pre-Exposure Prophylaxis (Females);   Behavioral: Cash Transfer Cohort (Females)
20 Recruiting Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
Condition: Atherosclerosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.